DH vs. JAMF, CERT, SPT, GDYN, NABL, PD, IAS, OPRA, MTTR, and ZUO
Should you be buying Definitive Healthcare stock or one of its competitors? The main competitors of Definitive Healthcare include Jamf (JAMF), Certara (CERT), Sprout Social (SPT), Grid Dynamics (GDYN), N-able (NABL), PagerDuty (PD), Integral Ad Science (IAS), Opera (OPRA), Matterport (MTTR), and Zuora (ZUO). These companies are all part of the "computer software" industry.
Definitive Healthcare vs.
Definitive Healthcare (NASDAQ:DH) and Jamf (NASDAQ:JAMF) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, community ranking, dividends, profitability, valuation, risk, media sentiment and analyst recommendations.
In the previous week, Definitive Healthcare had 3 more articles in the media than Jamf. MarketBeat recorded 5 mentions for Definitive Healthcare and 2 mentions for Jamf. Jamf's average media sentiment score of 0.49 beat Definitive Healthcare's score of 0.32 indicating that Jamf is being referred to more favorably in the news media.
Jamf has higher revenue and earnings than Definitive Healthcare. Jamf is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.
Definitive Healthcare has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500. Comparatively, Jamf has a beta of 0.37, indicating that its stock price is 63% less volatile than the S&P 500.
98.7% of Definitive Healthcare shares are owned by institutional investors. Comparatively, 93.8% of Jamf shares are owned by institutional investors. 14.8% of Definitive Healthcare shares are owned by insiders. Comparatively, 2.3% of Jamf shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Jamf received 30 more outperform votes than Definitive Healthcare when rated by MarketBeat users. Likewise, 70.13% of users gave Jamf an outperform vote while only 27.91% of users gave Definitive Healthcare an outperform vote.
Jamf has a net margin of -11.29% compared to Definitive Healthcare's net margin of -142.38%. Definitive Healthcare's return on equity of 1.76% beat Jamf's return on equity.
Definitive Healthcare currently has a consensus target price of $5.72, indicating a potential upside of 45.23%. Given Definitive Healthcare's stronger consensus rating and higher probable upside, research analysts plainly believe Definitive Healthcare is more favorable than Jamf.
Summary
Definitive Healthcare beats Jamf on 10 of the 18 factors compared between the two stocks.
Get Definitive Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for DH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Definitive Healthcare Competitors List
Related Companies and Tools
This page (NASDAQ:DH) was last updated on 1/21/2025 by MarketBeat.com Staff
Free DH Stock Alerts